Rebooting EU Medtech: Appetite For Urgent Discussions To Address Failing Regulations Grows
Executive Summary
Lack of predictability uncertainty over fees and inefficient working practices inherent in the current implementation of EU rules are all demanding a rethink in the EU’s current and future medtech rules. Industry expects discussions to kick off early next year.